- Exchange: Tokyo
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Wakamoto Pharmaceutical Co Ltd
+ Add to Watchlist4512:JP
268 JPY 4 1.47%As of 02:00:00 ET on 06/19/2013.
Snapshot for Wakamoto Pharmaceutical Co Ltd (4512)
| Open: | 272 | Day's Range: | 267 - 277 | Volume: | 9,000 |
|---|---|---|---|---|---|
| Previous Close: | 272 | 52wk Range: | 180 - 372 | 1-Yr Rtn: | +36.73% |
Key Statistics for 4512
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. TPX | - |
| Earnings Per Share (ttm) | -6.3800 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M JPY) | 9,336.67 |
| Shares Outstanding (M) | 34.84 |
| 30 Day Average Volume | 32,567 |
| Price/Book (mrq) | 0.7705 |
| Price/Sale (ttm) | 0.9890 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (JPY) | - |
| Last Dividend | 03/27/2013 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4512
No data available
Company Profile & Key Executives for 4512
WAKAMOTO PHARMACEUTICAL CO., LTD. produces and sells prescription and generic drug. The Company's products include vitamins, external medicine, toothpaste and toothbrushes, and drugs for digestive organs.
| Nobuyuki KamiyaPresident | Hideo SugamataSenior Managing Director |
| Arata IgarashiManaging Director | Hirokazu SuzukiDirector |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
4512 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page